Ligand (LGND) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $2.37
- EPS estimate
- $1.95
- EPS surprise
- +21.48%
- Revenue surprise
- +4.64%
- Revenue
- $63.7M
- Revenue estimate
- $60.9M
- Reported
- Aug 6, 2026
Ligand reported Q2 2026 results on August 6, 2026. Earnings per share were $2.37, ahead of the $1.95 estimate by 21.48%. Revenue was $63.7 million against a $60.9 million consensus. Compared with Q2 2025, EPS rose about 48% from $1.60 and revenue rose about 34% from $47.6 million.
Annual EPS in the table moved from $2.04 in 2022 to $6.10 in 2023, eased to $5.71 in 2024 and climbed to $8.04 in 2025. Revenue took a different path, falling from $219.6 million in 2022 to $131.4 million in 2023 before rising to $268.1 million in 2025. Q3 2025 holds the highs here, at $3.09 per share and $115.5 million in revenue. The first half of 2026 totals $4.00 per share, about 37% more than a year earlier. Over the last 20 quarters, Ligand beat the EPS estimate 16 times. The most recent miss was Q1 2026, at 10.23% below.
Ligand has reported Q3 between November 6 and November 9 in each of the past five years. That points to early November 2026 for the next report. It will show how Q3 compares with the $3.09 per share and $115.5 million in revenue from Q3 2025.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 6, 2026 | $1.95 | $2.37 | +21.48% | $63.7M | SEC |
| Q1 2026 | May 7, 2026 | $1.82 | $1.63 | −10.23% | $51.7M | SEC |
| Q4 2025 | Feb 26, 2026 | $1.50 | $2.02 | +34.93% | $59.7M | SEC |
| Q3 2025 | Nov 6, 2025 | $1.93 | $3.09 | +60.24% | $115.5M | SEC |
| Q2 2025 | Aug 7, 2025 | $1.42 | $1.60 | +12.57% | $47.6M | SEC |
| Q1 2025 | May 8, 2025 | $1.21 | $1.33 | +9.76% | $45.3M | SEC |
| Q4 2024 | Feb 27, 2025 | $1.19 | $1.27 | +6.72% | $42.8M | SEC |
| Q3 2024 | Nov 7, 2024 | $1.35 | $1.84 | +36.59% | $51.8M | SEC |
| Q2 2024 | Aug 6, 2024 | $1.06 | $1.40 | +32.55% | $41.5M | SEC |
| Q1 2024 | May 7, 2024 | $0.83 | $1.20 | +43.88% | $31.0M | SEC |
| Q4 2023 | Feb 27, 2024 | $0.66 | $1.38 | +108.84% | $28.1M | SEC |
| Q3 2023 | Nov 8, 2023 | $0.62 | $1.02 | +64.52% | $32.9M | SEC |
| Q2 2023 | Aug 8, 2023 | $0.64 | $1.42 | +123.27% | $26.4M | SEC |
| Q1 2023 | May 4, 2023 | $0.89 | $2.28 | +155.03% | $44.0M | SEC |
| Q4 2022 | Feb 22, 2023 | $0.77 | $0.75 | −2.96% | $50.4M | SEC |
| Q3 2022 | Nov 7, 2022 | $0.28 | $0.26 | −5.09% | $66.1M | SEC |
| Q2 2022 | Aug 8, 2022 | $0.28 | $0.66 | +139.50% | $57.4M | SEC |
| Q1 2022 | May 4, 2022 | $0.42 | $0.37 | −11.45% | $45.7M | SEC |
| Q4 2021 | Feb 17, 2022 | $0.88 | $1.16 | +31.39% | $72.5M | SEC |
| Q3 2021 | Nov 9, 2021 | $0.68 | $1.02 | +49.40% | $64.8M | SEC |
Quarterly revenue
Frequently asked questions
When did Ligand (LGND) last report earnings?
Ligand last reported on Aug 6, 2026, covering fiscal Q2 2026.
Did LGND beat earnings estimates?
Yes. Ligand reported EPS of $2.37 for Q2 2026 against a $1.95 estimate — a 21.48% beat.
How much revenue did LGND report last quarter?
Ligand reported $63.7M in revenue for Q2 2026, against a consensus estimate of $60.9M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.